NORWALK, Conn. – The Norwalk-based Multiple Myeloma Research Foundation has announced changes in its leadership positions.
New Canaan's Kathy Giusti, the founder and chief executive officer of the MMRF and the Multiple Myeloma Research Consortium, is now the executive chairman of the MMRF board of directors. Walter Capone will become president and chief executive officer and will report to Giusti. Dana LaForge will continue to serve on the board.
“As we participate in the global cancer research platform, we are very excited to be collaborators in developing opportunities that strengthen and speed our quest for a cure,” said Giusti. “We see new hope every day as we share big data to drive discovery and pursue innovative approaches in immune therapy, targeted drugs and trial design.
"I look forward to my new role that allows me to continue to support our commitment to myeloma patients, focus on expanding critical corporate partnerships, and launch the largest capital campaign in the company’s history.”
Multiple myeloma is a cancer of the plasma cell and is the second most common form of blood cancer. Nearly 25,000 adults will be diagnosed with multiple myeloma in 2014.
Twin sisters Karen Andrews and Kathy Giusti established the MMRF in 1998 as a nonprofit organization soon after Kathy's diagnosis with the disease.
For more information about the MMRF, visit themmrf.org.